T. Rowe Price Associates’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.56M | Buy |
|
|||||
|
2025
Q2 | $1.43M | Buy |
|
|||||
|
2025
Q1 | $1.19M | Buy |
|
|||||
|
2024
Q4 | $893K | Buy |
|
|||||
|
2024
Q3 | $741K | Buy |
|
|||||
|
2024
Q2 | $661K | Buy |
|
|||||
|
2024
Q1 | $619K | Buy |
|
|||||
|
2023
Q4 | $558K | Buy |
|
|||||
|
2023
Q3 | $406K | Sell |
|
|||||
|
2023
Q2 | $574K | Buy |
|
|||||
|
2023
Q1 | $499K | Sell |
|
|||||
|
2022
Q4 | $585K | Buy |
|
|||||
|
2022
Q3 | $386K | Buy |
|
|||||
|
2022
Q2 | $186K | Sell |
|
|||||
|
2022
Q1 | $4.03M | Sell |
|
|||||
|
2021
Q4 | $14.7M | Buy |
|
|||||
|
2021
Q3 | $13.4M | Sell |
|
|||||
|
2021
Q2 | $21.3M | Buy |
|